Italy announced on Wednesday that it would limit the use of AstraZeneca's Covid-19 vaccine for people over 60, following reports of a link with rare cases of blood clots.
It has been decided "to recommend the use in preference to people over 60," Italian government scientific adviser Franco Locatelli told a news conference hours after the European Medicines Agency (EMA) proposed listing the risk of blood clots as a rare side effect of the Anglo-Swedish vaccine.
Related News
- Confusion over AstraZeneca dose undermines confidence in vaccines, Test Achats finds
- Temporary limit on AstraZeneca vaccine will have 'minimal impact' on vaccination rollout
- Vaccine link to Belgium's one fatal blood clotting case remains unclear
- Belgium will temporarily only give AstraZeneca vaccine to over-55s
- 'Possible link' between AstraZeneca vaccine and rare blood clots, says EMA
The Brussels Times